ALEXION PHARMACEUTICALS INC·4

Mar 1, 7:44 PM ET

ALEXION PHARMACEUTICALS INC 4

4 · ALEXION PHARMACEUTICALS INC · Filed Mar 1, 2017

Insider Transaction Report

Form 4
Period: 2017-02-28
BELL LEONARD
DirectorCEO
Transactions
  • Sale

    Common Stock, par value $.0001 per share

    2017-02-28$131.71/sh2,738$360,622391,910 total
  • Sale

    Common Stock, par value $.0001 per share

    2017-03-01$132.50/sh1,240$164,300390,670 total
Footnotes (3)
  • [F1]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
  • [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $131.00 - $131.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
  • [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $132.00 - $132.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.

Documents

1 file
  • 4
    wf-form4_148841544058379.xmlPrimary

    FORM 4